Sinilnikova, O., Antoniou, A., Simard, J., Healey, S., Leone, M., Sinnett, D., . . . Stoppa-Lyonnet, D. (2009). The TP53 Arg72Pro and MDM2 309G > T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Chicago Style CitationSinilnikova, OM, et al. The TP53 Arg72Pro and MDM2 309G > T Polymorphisms Are Not Associated With Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. 2009.
MLA CitationSinilnikova, OM, et al. The TP53 Arg72Pro and MDM2 309G > T Polymorphisms Are Not Associated With Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. 2009.
Warning: These citations may not always be 100% accurate.